Form 4 for ATEX Anterix Inc.
Accepted 2024-12-11 00:00:00 ET · period of report 2024-12-09 · accession 0001304492-24-000138 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-11 | 2024-12-09 | ATEX | OBRIEN MORGAN E | Executive COB, Dir | F - Tax | $34.05 | -76.4K | 37.6K | -67% | -$2.60M |
| D | 2024-12-11 | 2024-12-09 | ATEX | OBRIEN MORGAN E | Executive COB, Dir | M - OptEx | $25.00 | +90.0K | 114.0K | +375% | +$2.25M |
| D | 2024-12-11 | 2024-12-09 | ATEX | OBRIEN MORGAN E | Executive COB, Dir | M - OptEx | $0.00 | -90.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-09 | F | D | 76,391 | $34.05 | 37,582 | D | — | — | (F1) This price reflects the closing price of the Issuer's Common Stock on the Nasdaq Capital Market on December 9, 2024. |
| 2 | Common | Common Stock | 2024-12-09 | M | A | 90,000 | $25.00 | 113,973 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-12-09 | M | D | 90,000 | $0.00 | 0 | D | $25.00 · — to 2025-01-29 | 90,000 Common Stock | (F2) The option shares are fully vested and the option would have expired by its terms on January 29, 2025. |